You can edit and use this template for any purpose (personal or commercial) of your website. You can modify text and images to suit your own website or client websites. You are NOT allowed to ...

Vertex has doubled down on cell-based therapies for type 1 diabetes (T1D), buying ViaCyte in a $320 million deal that it says will accelerate development of its own candidate VX-880. The deal has ...

Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis (CF). It markets TRIKAFTA/KAFTRIO for people with CF ...

After hours: March 26 at 7:34:24 PM EDT Loading Chart for VRTX ...